500087 announcements Cipla Ltd. announcements and dividends declared BSE
Cipla Ltd. Complete list of announcements declared & dividend announcements by Cipla Ltd. 500087
Cipla Ltd. 500087 listed on BSE and deals inAnnouncements and dividends declared by Cipla Ltd. 500087
Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%
Cipla reported a 35% year-on-year decline in second-quarter net profit to Rs 878 crore, with revenue and EBITDA also falling amid weaker North American sales. India revenue grew 12%, while US regulatory approval and a biosimilar partnership supported its p
Announcement as on 27 October 2026
Market wrap: Bajaj Finance, Cipla, Nestle India, Eternal top gainers and losers on Nifty and Sensex on Thursday
Indian equity markets fell for a third consecutive session as weak global cues and sustained selling weighed on sentiment. The Nifty 50 declined 0.54% to 22,688, while the Sensex dropped 0.62% to 73,249.
Announcement as on 22 October 2026
Market wrap: Cipla, ONGC, HDFC Life, Bajaj Finance top gainers and losers on Nifty and Sensex on Thursday
Indian equities ended sharply lower, with the Nifty falling 1.64% and Sensex 1.67%, as rising bond yields and crude prices pressured sentiment. Broader indices declined, India VIX surged 22%, financial stocks led losses, and market breadth remained firmly
Announcement as on 24 September 2026
Cipla partners with Qilu to license, supply Keytruda biosimilar in US
Drug major Cipla Ltd on Thursday said its wholly owned subsidiary, Invagen Pharmaceuticals Inc, has entered into a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to the cancer drug Keytruda in the United States.
Announcement as on 04 September 2026
Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s cancer drug Keytruda. Qilu will handle development, approvals, manufacturing and supply, while Cipla USA will commercial
Announcement as on 04 September 2026
Announcements by Cipla Ltd. first page | Next page | Prev page |
500087 Cipla Ltd. current price & indicator signals
Recent prices of 500087 Cipla Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 18 Wed Nov 2026 | 1420.00 | 1382.00 to 1435.15 | 2.68% | 2.38 times |
| 17 Tue Nov 2026 | 1383.00 | 1382.65 to 1398.80 | -0.79% | 0.37 times |
| 16 Mon Nov 2026 | 1394.00 | 1390.00 to 1405.70 | 0.07% | 0.22 times |
| 13 Fri Nov 2026 | 1393.00 | 1393.00 to 1418.10 | -1.21% | 3.75 times |
| 12 Thu Nov 2026 | 1410.00 | 1399.40 to 1417.05 | -0.49% | 1.53 times |
| 11 Wed Nov 2026 | 1417.00 | 1406.35 to 1419.70 | 0.78% | 0.64 times |
| 09 Mon Nov 2026 | 1406.00 | 1397.45 to 1421.00 | 1.88% | 1.59 times |
| 30 Fri Oct 2026 | 1380.00 | 1360.60 to 1381.25 | 1.69% | 0.22 times |
| 29 Thu Oct 2026 | 1357.00 | 1347.25 to 1372.10 | -0.22% | 0.38 times |
| 28 Wed Oct 2026 | 1360.00 | 1327.05 to 1368.00 | 0.74% | 0.37 times |
| 27 Tue Oct 2026 | 1350.00 | 1319.40 to 1372.45 | -0.22% | 0.92 times |
| 26 Mon Oct 2026 | 1353.00 | 1332.00 to 1359.90 | 1.2% | 0.44 times |
Videos related to: 500087 announcements Cipla Ltd. announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


